These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2613353)

  • 1. Acute aluminemic encephalopathy in chronic renal failure: the citrate factor.
    Bakir AA
    Int J Artif Organs; 1989 Dec; 12(12):741-3. PubMed ID: 2613353
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperaluminemia in renal failure: the influence of age and citrate intake.
    Bakir AA; Hryhorczuk DO; Ahmed S; Hessl SM; Levy PS; Spengler R; Dunea G
    Clin Nephrol; 1989 Jan; 31(1):40-4. PubMed ID: 2914409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids.
    Kirschbaum BB; Schoolwerth AC
    Am J Med Sci; 1989 Jan; 297(1):9-11. PubMed ID: 2913801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citric acid in calcium effervescent tablets may favour aluminium intoxication.
    Dorhout Mees EJ; Basçi A
    Nephron; 1991; 59(2):322. PubMed ID: 1956499
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperaluminaemia associated with oral citrate and aluminium hydroxide.
    Kirschbaum BB; Schoolwerth AC
    Hum Toxicol; 1989 Jan; 8(1):45-7. PubMed ID: 2714810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate binders in hyperphosphatemia of chronic renal failure.
    Wasan SM; Godley PJ
    DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors in aluminum toxicity in children with chronic renal failure.
    Santos F; Massie MD; Chan JC
    Nephron; 1986; 42(3):189-95. PubMed ID: 3511396
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of aluminium absorption by effervescent analgesic tablets in a haemodialysis patient.
    Main J; Ward MK
    BMJ; 1992 Jun; 304(6843):1686. PubMed ID: 1633526
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminum-citrate interaction in end-stage renal disease.
    Rudy D; Sica DA; Comstock T; Davis J; Savory J; Schoolwerth AC
    Int J Artif Organs; 1991 Oct; 14(10):625-9. PubMed ID: 1748529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of aluminium toxicity in a 'low incidence' area.
    Winney RJ; Cowie JF; Cumming AD; Short AI; Smith GD; Robson JS
    Contrib Nephrol; 1984; 38():47-58. PubMed ID: 6713900
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered biodistribution of gallium-67 in a patient with aluminum toxicity treated with desferoxamine.
    Brown SJ; Slizofski WJ; Dadparvar S
    J Nucl Med; 1990 Jan; 31(1):115-7. PubMed ID: 2295931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide.
    Coburn JW; Mischel MG; Goodman WG; Salusky IB
    Am J Kidney Dis; 1991 Jun; 17(6):708-11. PubMed ID: 2042654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum toxicity in children with chronic renal failure.
    Polinsky MS; Gruskin AB
    J Pediatr; 1984 Nov; 105(5):758-61. PubMed ID: 6389807
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
    Nestel AW; Meyers AM; Paiker J; Rollin HB
    Nephron; 1994; 68(2):197-201. PubMed ID: 7830856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemoptysis and altered sensorium in a hemodialysis patient.
    Olivero JJ
    Hosp Pract (Off Ed); 1993 Mar; 28(3A):77-8. PubMed ID: 8450006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.